Tjeerd Barf
FounderCo-founder & CEO at Artica Therapeutics · Independent Pharma Industry Expert at Cytura Therapeutics
Oss, North Brabant, Netherlands
FoundedArtica Therapeutics
Find your path to Tjeerd
270 people in our graph share verified history with Tjeerd — schools, employers, funds. One of them is your warm intro.
About
Tjeerd Barf is the CEO and Founder of Artica Therapeutics B.V. He has more than 25 years of experience in pharmaceutical R&D across startup, mid-size, and large pharma settings, working in metabolic disease, immunology, and oncology. His areas of focus include drug discovery, medicinal chemistry, structure-based drug design, covalent drugs, and CMC, with target families spanning kinases, dehydrogenases, phosphatases, cathepsins, nuclear receptors, and GPCRs.
Co-founder & CEO at Artica Therapeutics
Intro paths
In turn, Tjeerd can intro founders to Artica Therapeutics's investors below.
Artica Therapeutics's investors · 4
Co-founders at Artica Therapeutics

Independent Pharma Industry Expert at Cytura Therapeutics
Intro paths
In turn, Tjeerd can intro founders to Cytura Therapeutics's investors below.
Cytura Therapeutics's investors · 1
Experience
- ARTICA TherapeuticsCEO and Foundercurrent2020 — presentLeiden, The Netherlands
- 3Ceptor Design BVOwnercurrent2020 — presentRavenstein, North Brabant, Netherlands
- Covalution BioSciences BVCo-founder and Managing Directorcurrent2012 — presentRavenstein
- Genase TherapeuticsVP Chemistrycurrent2019 — presentOss, the Netherlands
- Cytura TherapeuticsBoard Member and SAB Member2019 — 2023Oss, The Netherlands
- Acerta Pharma BVEVP Chemistry - Co-founder2013 — 2020Oss, The Netherlands
- Acerta Pharma BVBoard Of Directors2016 — 2019Oss, The Netherlands
- Acerta Pharma BVHead of Chemistry - Founder2011 — 2013
- MSD / OrganonProject Team Leader - Senior Research Scientist2005 — 2011Oss, the Netherlands
- Biovitrum AB (publ)Project leader2001 — 2005Greater Stockholm Metropolitan Area
- Pharmacia Upjohn ITChemistry Team Leader1997 — 2001Greater Uppsala Metropolitan Area
Skills & more
+2 more
OncologyResearch and Development (R&D)Languages Dutch · English · German · Swedish
From Tjeerd's professional profile.
Frequently asked questions
- Who is Tjeerd Barf?
- Tjeerd Barf is the CEO and Founder of Artica Therapeutics B.V. He has more than 25 years of experience in pharmaceutical R&D across startup, mid-size, and large pharma settings, working in metabolic disease, immunology, and oncology. His areas of focus include drug discovery, medicinal chemistry, structure-based drug design, covalent drugs, and CMC, with target families spanning kinases, dehydrogenases, phosphatases, cathepsins, nuclear receptors, and GPCRs.
- Where does Tjeerd Barf work?
- Tjeerd Barf is Co-founder & CEO of Artica Therapeutics and Independent Pharma Industry Expert at Cytura Therapeutics.
- What companies did Tjeerd Barf found?
- Tjeerd Barf founded Artica Therapeutics.
- Where did Tjeerd Barf go to school?
- Tjeerd Barf studied at University of Groningen (PhD, Medicinal Chemistry).
Founder mafias
University of Groningen mafia48
Also came through, then founded or led a company.
Same school
Also attended University of Groningen198
+ 192 more
Shared employers
Also worked at ARTICA Therapeutics3
Also worked at Cytura Therapeutics1
Also worked at Acerta Pharma BV4
Also worked at MSD / Organon260
+ 254 more





























